ADORE: A randomized, double-blind, placebo-controlled study to assess the effect of repeated subcutaneous doses of SAR425899 on energy expenditure and safety in overweight to obese male and female subjects

NCT03376802

ADORE: A randomized, double-blind, placebo-controlled study to assess the effect of repeated subcutaneous doses of SAR425899 on energy expenditure and safety in overweight to obese male and female subjects

Associated Conditions

Obesity-Drug Study

Principal Investigator

Sponsor

Sanofi Pasteur

The primary purpose of the study is to test if SAR425899 can affect energy expenditure.